Rights and permissions
About this article
Cite this article
Disease-modifying therapies for MS exceed $1 million per QALY. Pharmacoecon. Outcomes News 634, 5 (2011). https://doi.org/10.2165/00151234-201106340-00013
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201106340-00013